Havas and Vencore Form Patient Analytics JV

In the US, health and communications network Havas Health and defense analytics specialist Vencore have formed a joint venture (JV) called HVH Patient Precision Analytics, to provide data and insights into the rare and niche disease market.

HVH combines predictive modeling and machine learning with therapeutic medical expertise to collect and analyzes large amounts of disparate health data and study the journeys of patients. As part of the new initiative, it is launching its first service offering, to enable biopharma firms to find undiagnosed patients with a rare disease.

The JV will be led by Steve Costalas from Vencore, who will serve as CEO, and Jeff Ceitlin from Havas Health, who will serve as Chief Commercial Officer. Commenting on the launch, Costalas said: 'This joint venture gives our proven defense-grade patient finder technology increased breadth and scale to better serve the pharmaceutical industry. Our potentially life-saving analytical tools will assist the earlier identification and diagnosis of disease in patients across the country'.

Web site: www.hvhprecision.com.